III Steering Committee Meeting. Mexico, DF. May 2003. Annex 4. Bioequivalence Working Group. J. Molzon
III Steering Committee Meeting. Mexico, DF. May 2003. Annex 4. Bioequivalence Working Group. J. Molzon 31 p. Justina A. Molzon, M.S. Pharm., J.D. Associate Director for International Affairs Center for Drug Evaluation and Research/USFDA |